NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Osteal Therapeutics

Osteal Therapeutics

Private
Dallas, TexasHealthcare & Life Scienceshttps://www.ostealtx.com/

Last Round

Series D

Jun 5, 2024

Est. Valuation

$265M

Total Funding Raised

$110.8M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Osteal Therapeutics is a biotechnology company that develops drug-device combination products for the treatment of orthopedic infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

periprosthetic joint infectionPJIlocalized drug deliveryrevision arthroplastydrug-device combinationbioresorbable hydrogelorthopedic infectionvancomycin deliverysurgical site infectionbiopharmaceuticalclinical-stage biotechmedtechortho-biologics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Osteal Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Osteal Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Osteal Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DJun 5, 2024
Series CSep 21, 2023
Series BMar 8, 2022
Series AApr 18, 2018

Key People

Founding team and executive leadership

Jude Paganelli

Chief Technology Officer

Executive Team

Osteal Therapeutics Investors

Notable investors and investment history

Osteal Therapeutics investors
InvestorRounds
HM Venture PartnersSeries D, Series C
Gideon Strategic PartnersSeries D, Series C
HM CapitalSeries D, Series C, Series B
Johnson & Johnson Innovation - JJDC, Inc.Series C, Series B, Series D, Series A
Medvest CapitalSeries B, Series C, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2026

    Monthly visitors grew 79% MoM.

  • Jun 5, 2024

    $50M round led by Zimmer Biomet.

Osteal Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Osteal Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Osteal Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersDallas, Texas
Employee Range56
Year Founded2013
Last FundingJun 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.